Sales & Marketing News | pharmaphorum

News

Grifols files drug for rare bleeding disorder in the US

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

News

11 blockbuster drugs to look out for in 2025

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

News

Scrabble letters spelling out 'Deep Breath'

Verona says COPD drug is off to a flying start

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

News

MSD buys Irish vaccines plant from WuXi for €500m

MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.

News

Novo Nordisk asks FDA not to allow GLP-1 compounding

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

News

Patient organisations 'too influenced by corporate funders'

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on pharma funding.

Grifols files drug for rare bleeding disorder in the US

11 blockbuster drugs to look out for in 2025

Verona says COPD drug is off to a flying start

MSD buys Irish vaccines plant from WuXi for €500m

Novo Nordisk asks FDA not to allow GLP-1 compounding

Patient organisations 'too influenced by corporate funders'

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks